Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.
Treatment for ADHD is similar for adolescents and adult patients.
There are a number of new treatments and therapies coming on board for attention deficit/hyperactivity disorder (ADHD).
During the annual Neuroscience Education Institute Max! Virtual meeting, David Goodman, MD, FAPA, assistant professor of psychiatry and behavioral sciences at Johns Hopkins School of Medicine, will present 5 different times about ADHD and some new insights into the disorder.
Goodman explained some of the confusion in ADHD he will address during 1 of his presentations will be the hierarchy of ADHD treatments. Currently, there are at least 29 different ADHD treatments coming from multiple medication families, leading to some confusion among doctors over what the right treatment ultimately is.
Goodman will also look at what the options are for doctors should a patient not respond to the first option for ADHD treatment.
He will also take a deeper dive into dosing during the virtual conference, trying to come up with a best practices checklist clinicians can use to find the right dosing for a given patient.
In the final presentation, Goodman will look at the connection between autism and ADHD and what the common comorbidities could be.